Back to Search
PATRICK GILLIGAN, PH.D.
PH.D.
Counseling Psychologist
NPI: 1225063985Individual
Specialties, Licenses & Credentials
Counseling PsychologistPrimary
Psychologist — Counseling
Code: 103TC1900X
PSY8789(CA)
Research & Publications (20)
Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?
PMID 18256226·J Clin Microbiol·2008
4-observational
Application of comparative genomics to the analysis of vertebrate regulatory elements.
PMID 15163354·Brief Funct Genomic Proteomic·2004
7-preclinical
Impact of clinical practice guidelines on the clinical microbiology laboratory.
PMID 15070978·J Clin Microbiol·2004
6-review
Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseases.
PMID 15338958·Curr Opin Drug Discov Devel·2004
6-review
Therapeutic challenges posed by bacterial bioterrorism threats.
PMID 12354556·Curr Opin Microbiol·2002
6-review
Fugu and human sequence comparison identifies novel human genes and conserved non-coding sequences.
PMID 12234665·Gene·2002
4-observational
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.
PMID 10968277·Bioorg Med Chem·2000
7-preclinical
GSM cell phones can interfere with ionizing radiation dose monitoring equipment.
PMID 11064654·Br J Radiol·2000
8-other
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents.
PMID 10794681·J Med Chem·2000
6-review
8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.
PMID 19361210·J Med Chem·2009
7-preclinical
Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis.
PMID 19225098·J Clin Microbiol·2009
8-other
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
PMID 19361209·J Med Chem·2009
7-preclinical
Reining in RNA. Workshop on intracellular RNA localization and localized translation.
PMID 18084187·EMBO Rep·2008
7-preclinical
Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center.
PMID 17137846·J Cyst Fibros·2007
4-observational
SOCRATES episode II (synopsis of cochrane reviews applicable to emergency services episode II): the return of the series II.
PMID 17251619·Emerg Med J·2007
8-other
Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: structure-activity relationships and computational modeling.
PMID 17402721·J Med Chem·2007
7-preclinical
SOCRATES Episode II (synopsis of Cochrane reviews applicable to emergency services Episode II): the return of Series III.
PMID 17582042·Emerg Med J·2007
6-review
Is there value in susceptibility testing of Pseudomonas aeruginosa causing chronic infection in patients with cystic fibrosis?
PMID 17140346·Expert Rev Anti Infect Ther·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 744 NARDO RD
ENCINITAS, CA 92024 - Phone
- (760) 436-9813
Quick Facts
- NPI
- 1225063985
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile